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The Respiratory Tract and
the Environment
by Joseph D. Brain*
The primary determinants ofpulmonary disease are environmental. The same thinness and delicacy of
the air-blood barrier which allows rapid exchange of oxygen and carbon dioxide also reduce its effective-
ness as a barrier to inhaled allergens, carcinogens, toxic particles, and noxious gases, and micro-
organisms. Adults breathe 10,000 to 20,000 liters of air daily. This volume of air contains potentially
hazardous contaminating particles and gases. Future research should explore the diverse physiological
mechanisms which prevent the accumulation and deleterious action of inhaled particles and gases. Since
most pulmonary diseases are either initiated by or at least aggravated by the inhalation of particles and
gases, the role of environmental factors in the development of respiratory disease is an area worthy of
condnued support.
Functions of the Respiratory
System
Human beings cannot live without producing ade-
quate amounts of energy, which is produced by ox-
idizing the organic molecules in food. Thus the con-
sumption of oxygen and the production of carbon
dioxide, a waste product of ATP synthesis, are in-
dispensable to life. It follows that the human body
must have an organ designed to exchange carbon
dioxide and oxygen between the circulating blood
and the atmosphere in sufficient volumes to sustain
life. Within the lungs are hundreds of millions of
alveoli which form a surface of approximately
70 M2. Blood flowing through the lungs comes
within 1 am of gas contained in the alveoli. How-
ever, the respiratory tract is faced with conflicting
demands. It must be an efficient organ of gas ex-
change, but it must also create a protective barrier
which effectively excludes unwanted, harmful
agents.
Three processes are essential for the transfer of
oxygen from outside air to the blood flowing
through the lung: (1) ventilation, (2) perfusion, and
(3) diffusion within the air spaces and across the
air-blood barrier. Ventilation is the tidal process in
which air is moved in bulk between the atmosphere
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and the lung. Perfusion is the action of the car-
diovascular system in pumping blood throughout
the lungs. Diffusion is the passive movement of
gases down a concentration gradient between the
alveolar gas and pulmonary capillary blood.
In order to deliver the inhaled gas to the alveolar
surface uniformly, the lung has an elaborate dis-
tribution system. After moving through the nasal
cavity or through the mouth, air reaches the throat
or pharynx. Unless swallowing occurs, the epiglot-
tis does not cover the larynx, and the gas passes
through the larynx into the trachea. The trachea
branches into left and right bronchi, which branch
repeatedly until the alveoli are reached.
Movement of air into the lungs is caused by the
action of the respiratory muscles which expand the
chest wall so that the lungs till passively. At the end
of a normal expiration, a large amount of gas re-
mains in the lungs. Both the rate at which breathing
occurs (respiratory frequency) and the amount of
air coming in with each breath (tidal volume) are
variable and can be altered to match metabolic de-
mands. The ventilation rate is adjusted by the brain
to keep the concentration of oxygen and carbon
dioxide in the alveoli relatively constant.
Although ventilation is essential, gas exchange
does not occur unless blood is uniformly distributed
throughout the lungs. The right side of the heart
pumps venous blood which is high in carbon diox-
ide and low in oxygen. The pulmonary blood ves-
sels are highly branched, and a thin film ofblood is
October 1977 113spread just beneath the alveolar surface.
The third requirement for gas exchange in the
lungs is diffusion. Diffusion is very effective over
small distances. In the alveoli, the blood is sepa-
rated from the air by two specialized layers ofcells,
which together are less than I Am thick. The gas-
exchange capability of the lungs must be linked to
the needs of the whole body by means of the cir-
culatory system and by the unique properties ofthe
blood.
During the last decade, it has become obvious
that the lung also has many nonrespiratory func-
tions; for example, the endocrine function of the
pulmonary circulation has been emphasized. The
lungs metabolize vasoactive substances and may be
involved in such complex humoral processes as
blood pressure homeostasis. The endothelial cells
in the lung alter bradykinin, angiotensin-l, and
prostaglandins of the E and F series. Preliminary
evidence also suggests that the lung may synthesize
prostaglandins E2, F2a, G2, and H2. Too few studies
involving the uptake and release of pharmacologic
substances in the lung have been conducted on
human beings, although there is substantial infor-
mation from animal experiments.
The Lung as a Portal of Entry:
Pathways of Toxic Materials from
the Outer to the Inner
Environment
The respiratory tract is the most common route
ofentry for toxic particles present in the work envi-
ronment and the inhalation of particles in polluted
air by the general population is also of great con-
cern. Furthermore, the major portal of entry for
infectious particles is the respiratory tract; inhaled
particles from tobacco smoke now represent the
most important cause of emphysema, bronchitis,
and lung cancer. This section briefly summarizes
the nature of particle deposition and clearance in
the respiratory tract. These principles have broad
application to both toxic and therapeutic aerosols
which are inhaled. Excellent reviews of this area
are readily available (1-3).
Deposition is the process that determines what
fraction ofthe inspired particulates will be caught in
the respiratory tract and thus fail to exit with the
expired air. It is likely that all particles deposit after
touching a surface; thus the site ofinitial deposition
is the site ofcontact. Distinct physical mechanisms
operate on particles suspended in the inspired air,
causing them to move towards the surface of the
respiratory tract: inertial forces, sedimentation,
Brownian diffusion, interception, and electrostatic
forces.
Inertia is the tendency of moving particles to
resist changes in direction and speed. Repeated
breathing in the airways causes sudden changes in
the direction of air flow. However, because of in-
ertia, particles tend to continue in their original di-
rection, crossing air-flow streamlines and eventu-
ally making contact with the airway walls. Gravity
accelerates falling bodies downward, and terminal
settling velocity is reached when viscous resistive
forces are equal and opposite in direction to gravita-
tional forces. Respirable particles reach this con-
stant terminal or sedimentation velocity in less than
0.1 msec. Thus, particles are also removed as their
terminal velocity causes them to strike the airway
walls or alveolar surfaces. Aerosol particles also
undergo Brownian diffusion, a motion caused by
collisions ofgas molecules with particles suspended
in the air. This motion causes the particles to cross
streamlines and thus increases the probability that
they will deposit.
The effectiveness of these deposition
mechanisms depends on: (1) the anatomy ofthe res-
piratory tract, (2) the effective aerodynamic
diameters of the particles, and (3) the pattern of
breathing. These factors determine the fraction of
the inhaled particles that are deposited as well as
the site of deposition.
The anatomy of the respiratory tract is important
since it is necessary to know the diameters of the
airways, the frequency and angles ofbranching, and
the average distances to the alveolar walls. Fur-
thermore, when considered with the volumetric
flow rate, airway anatomy specifies the local linear
velocity of the air stream and the character of the
flow as a significant change in the effective anatomy
of the respiratory tract occurs when there is a
switch between nose and mouth breathing. There
are inter- and intraspecies differences in lung
morphometry; even within the same individual, the
dimensions ofthe respiratory tract vary with chang-
ing lung volume, aging and pathological processes.
The effective aerodynamic diameters of the par-
ticles affect the magnitude offorces acting on them.
For example, while inertial and gravitational effects
increase with increasing particle size, diffusion pro-
duces larger displacements as particle size de-
creases. This effective aerodynamic diameter is a
function of particle size, shape, and density. Hy-
groscopic properties may also alterparticle size both
within and without the respiratory tract. In order to
predict deposition patterns, it is essential to de-
scribe both the distribution and the mean of
aerodynamic diameters.
The remaining factor affecting deposition is the
breathing pattern. Minute volume defines the aver-
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lung and the total number of particulates to which
the lung will be exposed. Respiratory frequency
will affect the residence time ofaerosols in the lungs
and hence the probability of deposition by gravita-
tional and diffusional forces. Changing lung volume
will alter the dimensions of the airways and paren-
chyma.
Despite continuous exposure of the lung to par-
ticulates characteristic of occupational and urban
environments, the surfaces of the respiratory tract
are relatively free of foreign matter. Even the dis-
eased and blackened lungs of miners who succumb
to coal workers' pneumoconiosis, contain less than
10% of the dust originally deposited there. Even in
lungs seriously compromised by disease, the res-
piratory system is still surprisingly efficient at
cleaning itself. The healthy lung exhibits even
greater potency in the pursuit ofcleanliness. This is
the result of a complex system of respiratory de-
fense mechanisms which both prevents particle
entry and removes particles that have been depo-
sited. Clearance refers to the dynamic processes
that remove particulates from the respiratory tract;
it is the output ofparticulates previously deposited.
Highly soluble particles and gases dissolve rapidly
and are absorbed into the blood from the respira-
tory tract. Their metabolism and excretion resemble
that of an intravenously injected dose of the same
material.
Less soluble particles that deposited on the
mucus blanket covering pulmonary airways are
moved toward the pharynx by the cilia. Also pres-
ent in this moving carpet of mucus are cells and
particles which have been transported from the non-
ciliated alveoli to the ciliated airways. Similarly,
particles deposited on the ciliated mucus mem-
branes of the nose are propelled toward the
pharynx. There, mucus, cells, and debris coming
from the nasal cavities and the lungs meet, mix with
salivary secretions, and enter the gastrointestinal
tract after being swallowed. Since the particles are
removed with half-times of minutes to hours, there
is little time for solubilization of slowly dissolving
materials. In contrast, particles deposited in the
nonciliated compartments have much longer resi-
dence times; there, small differences in in vivo
solubility can have great significance.
A number of factors can affect the speed of
mucus flow. They may be divided into two
categories: those affecting the cilia themselves and
those affecting the properties of the mucus. The
following aspects of ciliary action may be affected
by environmental insult: the number of strokes per
minute, the amplitude of each stroke, the time
course and form of each stroke, the length of the
cilia, the ratio ofciliated to nonciliated area, and the
susceptibility of the cilia to intrinsic and extrinsic
agents that modify their rate and quality of motion.
The characteristics of the mucus are frequently
even more critical. The thickness of the mucus
layer and its rheological properties may undergo
wide variations.
Many studies reported in the literature do not
characterize ciliary motility and the quantity of the
mucus separately. In most cases the interaction of
the two processes, mucus transport, is the variable
that is measured. Most evidence suggests that
mucus secretion is a more sensitive process than is
ciliary activity. In many instances the quantity and
rheological characteristics of the polymeric gel
which constitutes mucus may be affected indepen-
dently of any change in the cilia.
Macrophages are usually credited with keeping
the alveolar surfaces clean and sterile. Alveolar
macrophages are large, mononuclear, phagocytic
cells found on the alveolar surface. They do not
form part of the continuous epithelial layer, which
is made up of pulmonary surface epithelial cells
(type I pneumonocytes) and great alveolar cells
(type II pneumonocytes). Rather, the alveolar ma-
crophages rest on this lining. These cells are largely
responsible for the normal sterility ofthe lung (4). It
is the phagocytic and lytic potential of the alveolar
macrophages that provides most of the known bac-
tericidal properties of the lungs. Like other phago-
cytes, alveolar macrophages are rich in lysosomes.
The lysosomes attach themselves to the
phagosomal membrane surrounding the ingested
pathogen. Then the lysosomal membranes become
continuous with the phagosomal membrane and the
lytic enzymes kill and digest the bacteria. Among
the hydrolases they are known to contain are pro-
teases, deoxyribonuclease, ribonuclease, f3-glu-
curonidase, and acid phosphatase. Although these
enzymes constitute an important aspect of the
lung's defensive posture, when kept in a chronically
activated state, this digestive capacity may serve to
damage pulmonary tissues. Release of lysosomal
enzymes, particularly proteases, from activated
macrophages and leukocytes may be involved in the
development of emphysema. Release may occur as
a consequence ofcell death, cell injury, or exocyto-
sis. Increased deposition of inert or infectious
particles acts to recruit additional macrophages and
thus the effect may be reinforced.
Hence, our concern is also directed toward their
ability to ingest nonliving, insoluble dust and de-
bris. Rapid endocytosis of insoluble particles pre-
vents particle penetration through the alveolar
epithelia and facilitates alveolar-bronchiolar trans-
port. Schiller (5) and later Sorokin and Brain (6)
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dusts can re-enter the alveolar wall; only free parti-
cles appear to penetrate. Thus phagocytosis plays
an important role in the prevention of the entry of
particles into the fixed tissues of the lung. Once
particles leave the alveolar surface and penetrate
the tissues subjacent to the air-liquid interface (type
I and II cells, interstitial and lymphatic tissues),
their removal is slowed. Particles remaining on the
surface are cleared with a biological half-time esti-
mated to be twenty-four hours in humans, while
particles that have penetrated into "fixed" tissues
are cleared with half-times ranging from a few days
to thousands of days. Therefore, the probability of
particle penetration is critical in determining the
clearance of particles from the non-ciliated regions
of the lungs.
Pathological processes, such as fibrosis, may also
impair particle clearance from these compartments.
The probability of particle entry into a fixed tissue
in which it would have a long biological half-time is
reduced ifthe particle is phagocytized by a free cell.
Therefore endocytosis emerges as a central theme
of macrophage activity and the ability to quantitate
endocytosis and to study variations in the rate of
endocytosis are essential to our understanding of
respiratory defense mechanisms. Only then can the
role of differing environmental conditions on en-
docytosis be understood. Endocytosis has been
much studied, but most techniques which are avail-
able measure phagocytosis in vitro. Attempts to
quantitate phagocytosis in vivAo are considerably
less frequent. Hepatic macrophages have been
studied as the major component of the reticuloen-
dothelial system and the rate of disappearance of
various particulate materials from the circulation is
well described. In contrast, the rate at which
phagocytosis occurs in the living lung is not well
established. Serial sacrifice and visual observation
can give some clues, but other techniques to esti-
mate endocytosis in vivo must be created.
During the last few years, it has become increas-
ingly obvious that not all pulmonary macrophages
are alveolar macrophages. Another important sub-
division of pulmonary macrophages is the airway
macrophage. These mononuclear cells are present
in the conducting airways, both of large and small
caliber. They may be present as passengers on the
mucus escalator, or they may be found beneath the
mucus lining, apparently adhering to the bronchial
epithelium. These airway macrophages probably
represent the result of alveolar-bronchiolar trans-
port of alveolar macrophages, although it has been
suggested that they are the product ofdirect migra-
tion of cells through the bronchial epithelium.
The third subdivision ofpulmonary macrophages
is interstitial macrophages found in the various
connective tissue compartments in the lung. These
include alveolar walls, sinuses of the lymph nodes
and nodules, and peribronchial and perivascular
spaces. Conn,ective tissue macrophages have been
considered in some detail by Sorokin and Brain (6).
All pulmonary macrophages are usually considered
to be relatives of monocytes and macrophages
throughout the body. This extended family includes
the Kupffer cells ofthe liver, the free and fixed ma-
crophages in the spleen, lymph nodes, bone marrow,
the peritoneal macrophage of the serous cavity, and
the osteoclasts ofbone.
A major aspect of macrophage function of great
importance to environmental health is the fate of
the pulmonary macrophage. Differences exist
among the varying classes of pulmonary macro-
phages and their fate must be considered sepa-
rately. Although little is known about the latter
stages of the life of the alveolar macrophage, the
possibilities are finite and easily enumerated.
They may be subject to alveolar-bronchiolar trans-
port mechanisms; they may enter the lymphatics or
connective tissue; or they may enter the circulation.
Finally, it is also possible that some never leave the
alveolar surface but persist for long periods oftime,
die there, and are then ingested and digested by
younger, more vigorous siblings.
There is speculation about the mechanisms re-
sponsible for alveolar-bronchiolar transport but lit-
tle supporting evidence exists. We do know that
most particles deposited in alveoli are ingested by
alveolar macrophages. Some ofthese cells find their
way to the bronchioles, and are then carried to the
pharynx by ciliary action. Migration through alveo-
lar pores, or other collateral pathways between ad-
jacent bronchial paths cannot be excluded. How-
ever, almost all of the macrophages are located on
the surfaces of alveoli or bronchi. Thus, it seems
unlikely that macrophages migrate to the bron-
chioles by penetrating between alveolar cells or by
emerging from lymphatic pathways.
Since some macrophages find their way to air-
ways, we must ask how these cells move to the
mucus escalator. It is possible that macrophages
exhibit directed locomotion because ofa concentra-
tion gradient of a chemotactic factor. The
phenomenon of chemotaxis is well studied in vitro.
This is particularly true for neutrophils, though
much less so for macrophages. Little is known
about the chemotactic behavior of alveolar ma-
crophages and no observations of alveolar ma-
crophage movement in situ have been made. There
is also no evidence to suggest that other tropisms,
such as geotropism, account for a purposeful mi-
gration of macrophages. Little direct experimental
Environmental Health Perspectives 116evidence suggests that the fluid lining ofthe alveolar
region moves mouthward, but many investigators
assume that it does.
The direct entry of alveolar macrophages into
lymphatic pathways and connective tissue has often
been suggested but rarely proved. The presence of
particle-containing macrophages in these compart-
ments is compelling evidence for many
investigators. However, the entry of alveolar
macrophages on the one hand and the entry ofbare
particles which are subsequently ingested by con-
nective tissue macrophages already present on the
other cannot be readily distinguished. During alveo-
lar clearance, some noningested particles may fol-
low lymphatic or vascular channels from alveoli
into the peribronchial, perivascular, or subpleural
adventitiae and thus penetrate into the connective
tissue of the lung. They are then stored by resident
macrophages already present. This pathway may be
more common when conditions favor increased
lymphatic permeability (pulmonary edema). Then a
greater number of particles might pass into these
vessels through clefts between endothelial cells, to
be carried along lymphatic drainage paths until fil-
tered out by macrophages located farther along in
lymphoid foci. Although inhaled particles can be
found in connective tissue macrophages, we are
aware of little evidence that implicates movement
of surface macrophages into connective tissue
compartments. We cannot, however, totally ex-
clude this possibility, however uncommon it may be.
Yet such penetration may be of consequence to en-
vironmental immunological lung disease since it pro-
vides a pathway for antigens in or on alveolar mac-
rophages to meet reactive lymphocytes in the con-
nective tissue.
When we consider the fate of airway macro-
phages, we should not assume that the particle-
containing mononuclear cells in the airways are
necessarily the product of alveolar-bronchiolar
transport. Some may be, but others may derive
from blood monocytes which have migrated from
the bronchial circulation directly to the airways. Al-
ternatively, they may derive from local monocytic
cell renewal systems (albeit undescribed) subjacent
to the bronchial epithelium.
Although the pulmonary macrophages are essen-
tial to host defense, the normal activity and move-
ment of pulmonary macrophages may also cause
harm. Because the macrophages are actively
phagocytic, inhaled toxic, radioactive, or car-
cinogenic particles become concentrated within
pulmonary macrophages. What begins as a diffuse
and relatively even exposure becomes highly
localized and nonuniform. "Hot spots" are formed,
and ifthresholds forcertain effects exist, these "hot
spots" of high dose may be of significance.
Similarly, adherence ofsome airway macrophages
to the airway epithelium may increase airway
exposure to inhaled toxic materials. More im-
portantly, perhaps, this close association with the
bronchial epithelium can lead to transbronchial
transport of inhaled particles and subsequent rein-
gestion by subepithelial connective tissue ma-
crophages. These cells, like their relatives in the
alveolar and airway compartments, also segregate,
retain. and perhaps metabolize carcinogenic and
other toxic particles.
Additional research needs to be carried out on
the structure and function of the pulmonary lym-
phatics. Classically, removal of particulates
through these channels was often considered to be
the major route for the clearance of material from
the lower respiratory tract. The importance of lym-
phatic clearance was probably exaggerated for sev-
eral reasons. Most of the early judgments were
based on morphological studies. Histological pro-
cedures, however, usually washed away the parti-
cles and cells being cleared via the airways, and so
the importance ofthis route was underestimated. It
is also difficult to draw quantitative conclusions
about dynamic processes when only static observa-
tions are available. The importance of a clearance
pathway is a function not only of the number of
particles in the pathway, but also of the rate at
which the particles are moving. Yet, although our
estimate of the percentage of particles cleared via
the lymphatics has dropped, our appreciation ofthe
importance of those particles entering the lym-
pathics has greatly increased. Because particles in
lymphatics are cleared slowly, they attain great sig-
nificance in the pathogenesis ofmany lung diseases.
When months and years have passed after exposure
to particles, these connective tissue burdens may
constitute the major reservoir ofretained particles.
Too little is also known regarding the nature and
properties of the air-blood barrier and the potential
for particles to penetrate it. The extent to which the
pulmonary capillary bed serves as a protective filter
eliminating debris, pathogens, and cells from the
circulating blood is not well described.
Little is known about the relative importance of
these clearance pathways in health and disease.
This lack is not without good reason. Difficult ex-
perimental protocols would be necessary to accu-
rately quantitate fractions carried by the different
clearance pathways. Theoretically, clearance by
the various routes could be measured by monitoring
the final common pathways for the airways, the
blood vessels and the lymphatics, using various in-
genious approaches. In the airways, a balance must
be made for material deposited more proximally if
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phatic route, a single final pathway would have to
be rationalized surgically for many collateral open-
ings into the bloodstream. Examination of lung
washings can be helpful in determining what part of
the uncleared particle residues are lodged in alveolar
macrophages and what part remain in the connec-
tive tissue. Further allowance must be made for the
possibility of crossover from one clearance path to
another, and it is important to separate the amount
of material cleared by extracellular from that
cleared by cellular mechanisms. As yet few studies
have provided quantitative details sufficient to de-
scribe and evaluate the complexities of alveolar
clearance. It is also likely that the extent to which
each pathway is used depends on the sizes, sol-
ubilities, and chemical properties of the deposited
particles, as well as the time elapsed after the ex-
posure and the degree of disease present.
Finally, it should also be remembered that depo-
sition and clearance must be considered together. Of
prime importance is the mass ofthe toxic substance
in the lung. The actual amount ofa substance in the
respiratory tract at any time is called the retention.
When the exposure is continuous, the equilibrium
concentration (achieved when the clearance rate
matches the deposition rate) is also the retention.
Thus, the relative rate constants of deposition and
clearance determine the equilibrium level; it is this
level, or retention integrated over time, and the
properties of the particle that are presumably re-
lated to the probability of a pathological response.
The Lung As a Target Organ
The lung is more than an important portal of
entry for environmental contaminants. It may also
be the critical organ-that is, the organ most likely
to be injured or compromised by inhaled particles
or gases. The abundance of specific diagnostic
labels for pulmonary diseases does not alter the re-
ality that universal mechanisms are operating. The
lung does respond to environmental insults in a va-
riety of ways, but its repertoire of responses is not
unique. The same catalog of responses and
mechanisms that characterizes the injured respira-
tory tract is also common to other organ systems.
Thus, general pathology (7, 8) provides an essential
backdrop for our understanding ofthe lung and en-
vironmental insults. Further progress in basic
pathology is essential. Table 1 lists some of the
changes that may take place in the lung. These
changes are direct or indirect consequences of the
physical and physiologic changes in cells brought
about by their contact with inhaled agents. The cell
responses, in turn, are responsible for loss and dis-
tortion ofalveoli, deposition ofnew alveolar tissue,
alterations in capillary and airway diameter, and
other anatomic alterations. These changes can
occur in combination, and their severity is related
to the duration and concentration of exposure.
Table 1. Mechanisms of pulmonary injury.
Proteolysis: Elastin and collagen destruction leading to em-
physema
Fibrosis: Increased connective tissue and scarring
Pulmonary edema and altered alveolar stability
Immunologic responses: Asthma, hypersensitivity lung dis-
eases, extrinsic allergic alveolitis
Inflammation: Irritation leading to mucosal edema, increased
mucus production and bronchitis, enhanced cell renewal
Altered susceptibility to infection: Cytotoxic and competitive
effects on macrophage function, altered mucociliary transport
due to changes in cilia or the quantity ofrheological character
of mucus
Degenerative changes: Necrosis, calcification, and autolysis
Bacterial, viral, and fungal infection
Pulmonary carcinogenesis
Although these pathological mechanisms opera-
tive in the lung are not exclusive to it, many arise
from unusual interactions with environmental fac-
tors. Certain mechanisms seem especially worthy
of further study. Connective tissue proteins are an
integral part of the lung. Collagen and elastin help
maintain alveolar, airway and vascular stability,
limit lung expansion, and contribute to lung recoil at
all lung volumes. Because oftheir fundamental role
in lung structure and function, collagen and elastin
balance (synthesis and degradation) deserve addi-
tional attention.
Two groups of environmental lung disease are
associated with aberrations of normal collagen and
elastin balance: emphysematous and fibrotic disor-
ders. To what extent this association involves
changes in the rate and nature ofsynthesis, or in the
role or nature of degradation of these proteins re-
mains speculative. Analysis of collagen composi-
tion, synthesis and degradation rates would be ex-
tremely useful both for diagnosis and for assess-
ment oftherapy ofthese connective tissue lung dis-
eases.
Unfortunately, the measurement of such
parameters in the lung is difficult. Quantitation of
rates and composition analysis have been described
(9), and can be performed on lung biopsy tissue.
However, the large number of different cell types,
and the heterogeneity, interactions and insolubility
oflung connective tissue have made accurate quan-
titation difficult. Improved approaches are needed
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may be very useful. Appropriate animal models of
emphysema and fibrosis could be exploited to quan-
titate the rates ofelastin and collagen synthesis and
degradation and to compare them to normal rates.
In emphysema, further studies are needed to ex-
amine the release of proteolytic enzymes from
leukocytes and macrophages, their effect on lung
cells, and the protection afforded by serum and lung
antiproteases. In fibrosis, investigations need to be
pursued studying the role of lymphocytes, ma-
crophages, fibroblasts and the effect of fibrogenic
agents on the collagen balance and on the replica-
tion and differentiation of each parenchymal cell
type (10).
Attention to this kind of injury has increased be-
cause of recent new knowledge about pulmonary
emphysema associated with inborn a,-antitrypsin-
inhibitor deficiency in humans. Inbalances between
proteolytic activity and its control or inhibition
have important implications as a generalized
mechanism of lung injury in other pulmonary path-
ological states caused by air pollution, or the inhala-
tion of occupational dusts.
Much more needs to be known regarding the na-
ture of the particles which trigger these connective
tissue diseases. Dust particles of appropriate size
and shape may deposit on alveolar surfaces and
stimulate production of excess collagen in the al-
veolar membrane. Particle size, shape, and durabil-
ity may be more important in fibrogenicity than
chemical characteristics. Asbestos, glass, and other
fibrous dusts all have been shown to stimulate col-
lagen synthesis (11). Fibers over 5 ,mm in length are
sometimes incompletely ingested by macrophages
(12, 13), and this may result in macrophage death or
release of mediators. Growth of fibroblasts in vitro
has been shown to require a solid supporting parti-
cle of critical minimum dimensions (14).
In addition, there is some evidence that fibro-
genesis may also occur as a two-step process (15).
This would especially apply to highly fibrogenic
particles such as silica which are highly symmetri-
cal in shape (5 um in diameter) and which are en-
gulfed by macrophages following deposition. Silica
has not been shown to exert a direct stimulatory
effect on fibroblasts. Rather, the interaction of a
particle with a macrophage is thought to release fac-
tors which stimulate local production ofcollagen by
fibroblasts. It is unlikely that macrophages differen-
tiate into collagen synthesizing fibroblasts (16).
Silica and asbestos have the added disadvantage
ofbeing cytotoxic to alveolar macrophages. Within
a few minutes they can cause lysis ofcells by direct
interaction with the plasma membrane, or, if suc-
cessfully ingested, in several hours cause rupture of
secondary lysosomes, releasing lysosomal hy-
drolases into the cytoplasm (17). The resulting dead
macrophages can become focal points for further fi-
brogenesis. In addition, the particles are released
anew on the alveolar surface to cause more irritation.
The responses ofthe lung to inhaled antigens and
allergens and the general area of environmental al-
lergic respiratory disease is emerging as an impor-
tant area of basic investigation. Advances in this
area may help to identify hyperreactors to a number
of industrially important materials, such as toluene
diisocyanate (TDI), cotton dust, molds (Farmer's
Lung and Bagassosis) and proteins causing a vari-
ety of forms of extrinsic allergic alveolitis. Im-
munological research addressed to the interaction
of these inhaled materials, connective tissue, pul-
monary cells and the lymphatic and vascular sys-
tems in the lung holds promise. Little is known
about the degradation of proteins deposited on the
respiratory tract surfaces. No doubt, in many in-
stances macrophages and pulmonary clearance de-
fend the body against excessive antigenic stimula-
tion. However, there may also be circumstances
when clearance pathways may cooperate with the
immune system and preserve and present im-
munogenic molecules to the immune system. Thus
the issue of how and when pulmonary macrophages
either suppress or enhance the immunogenicity of
antigens must be confronted.
It is known that several organic dusts can induce
an immune response in bronchial or alveolar tis-
sues. The type I and type III allergic reactions are
most commonly seen (18, 19). The type I response,
often termed immediate hypersensitivity, occurs
when an inhaled antigen reacts with cell-sensitizing
reagenic antibody (IgE). Cells of the bronchial wall
may be sensitized by this antibody, and react to
produce histamine, slow reacting substance of
anaphylaxis, and bradykinin. In persons sensitized
to a specific inhaled antigen, bronchoconstriction,
mucosal edema, excessive secretions, and
eosinophil infiltration occur.
The type III, or Arthus reaction, is characterized
by formation ofa complex between an antigen and a
precipitating antibody in the presence of comple-
ment. Tissue damage occurs from inflammatory re-
sponses caused by deposition of these complexes
along capillary basement membranes. The complex
is phagocytized by leukocytes and causes them to
release their lysosomes. In addition, histamine may
be released from mast cells producing local edema.
It is unknown whether antigens cross the alveolar
and capillar membranes to react with circulating an-
tibodies, or if lymphocytes and other reactive cells
on the alveolar and bronchiolar surfaces are re-
sponsible for the initial antibody-antigen reaction.
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nents of cotton dust need to be better described.
Particles inducing hypersensitivity pneumonitis
tend to be derived from fungal, bacterial, or serum
protein sources. Examples are the fungus
Thermnoactinomytes vulgaris in Farmer's Lung,
Bacillius subtilis in detergent workers' lung and bird
fanciers' disease (20-22).
Neoplastic responses to inhaled particles is
another area of major and growing concern. Al-
though smoking has been determined to be the
major cause of respiratory carcinogenesis, other
factors, especially industrially produced agents, are
gaining strong epidemiologic support. Asbestosis
has been correlated with bronchogenic carcinoma,
as well as mesothelioma of the pleura and
peritoneum (22). In addition, a synergistic effect be-
tween asbestos and cigarette smoking may cause a
substantially increased risk (23). Other agents im-
posing an increased risk are the polycyclic aromatic
hydrocarbons, radioisotopes, chromates, and com-
pounds involved in nickel refining (24-27).
Further study on the role of modifying influences
is of particular importance. The pathogenetic
mechanisms just discussed are in no way isolated
from important host variables. Dose-response
curves for interactions with environmental agents
are altered by many characteristics of the exposed
organism and its immediate environment. Some fac-
tors known to be important include: developmental
aspects, aging; genetic factors (AHH inducibility
and lung cancer, a,-antitrypsin deficiency, non-
specific airway reactivity); sexual differences;
species differences; interactions; circadian
rhythms; effects of pre-existing disease ("the sensi-
tive individual"); nutritional status; drugs; exercise
and altered ventilation; tolerance and adaptation;
and metabolic transformations.
Additional resear-ch concerning the effect of
these variables on the respiratory tract and other
organ systems is desirable.
Detection and Quantitation
of Lung Injury
An essential aspect of research on environmental
lung diseases relates to improved determination of
dose-response curves. We need to know with pre-
cision to what the respiratory tract is being ex-
posed. We must be able to measure lung damage
with similar precision and sensitivity.
It is now more widely appreciated that it is essen-
tial to specify the mass, particle size, and solubility
of inhaled particles. The ICRP lung model (2, 28)
emphasized the importance of these parameters in
determining burdens of particulates in the respira-
tory tract. It also provided a common framework
which can be used in summarizing experimental
data. But there are still major problems in quantitat-
ing the pulmonary dose. The relative merits of in-
tratracheal and inhalation exposures have recently
been discussed (29). Switching from nose to mouth
breathing and the effects ofexercise are largely un-
explored. Systematic descriptions of species differ-
ences are also essential. Although many species
have been used for studies in aerosol deposition, we
are unaware of any published systematic descrip-
tion of the differences between commonly used
laboratory animals. It is difficult to abstract such a
description from the literature because so many dif-
ferent kinds ofanimals and aerosols have been used
in various combinations.
The lung responds to environmental injury in
many ways. This diversity in response is matched
by a dazzling array of possible tests designed to
detect and quantitate lung damage. Table 2 lists
some ofthe approaches which commonly have been
used.
Almost all these approaches demand further re-
finement and many have serious limitations. For
example, one of the major problems with pulmo-
nary function tests is that they are rarely specific.
Measurements ofairway resistance reflect not only
direct alterations in the airway but may also reflect
parenchymal changes. For example, if the paren-
chyma becomes weakened by emphysema, support
for the airways is diminished. They become more
collapsible and airway resistance may increase.
Similarly, compliance measurements do not exclu-
sively reflect changes in the pulmonary paren-
chyma. If airway obstruction occurs, then the
parenchyma served by the airway will largely be
excluded and the lung will appear to be stiffer.
Further refinements are also needed for better
histologic, histochemical and morphometric
analysis of lung damage. Various fixation proce-
dures have been used for the fixation oflung tissue.
The main criteria are to preserve optimally the pul-
monary parenchyma in accordance with the desired
goal (examination ofultrastructure, investigation of
acellular alveolar lining layer, application of his-
tochemistry). Techniques exist which permit cutting
sections of whole lungs for pathologic examination.
These sections were originally intended for study-
ing the pathology ofcoal workers' pneumoconiosis,
and for comparison with radiological examinations
during the individuals'lives.In addition to evaluating
the lung sections qualitatively, quantitative mor-
phometric methods (30) have been developed to
assay the degree of tissue damage.
It would be desirable to identify enzymes or other
factors released from damaged lung into serum
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He dilution, Boyle's law, radiologic
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Flow volumes, partial flow volume curves,
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Fixation techniques. Problems: lung volumes, cellular heterogeneity
Gough sections
Reid index
Airway and alveolar dimensions: morphometric approaches




Uptake of tritiated thymidine
Problems in identifying cell types




Recognizable experimental pulmonary infections
(morbidity and mortality studies)





October 1977 121which could be sampled. Unfortunately, currently
no biochemical parameters are known which clearly
indicate the presence of toxic lung damage. It thus
becomes important to obtain more complete knowl-
edge about the biochemical events leading to cell
death or to repair and pulmonary cell proliferation.
Only then will we understand the mechanisms of
response and perhaps obtain useful indicators of
lung damage.
Techniques for sampling directly from the lung
are also desirable. Improved biopsy techniques
which can be used for repeated sampling from live
animals need to be developed. Lung lavage both in
sacrificed animals and in isolated segments ofliving
animals is also a valuable approach (see Table 2).
For example, research on pulmonary macrophages
often depends on our ability to isolate pure popula-
tions of macrophages from the lungs of animals and
man. Alveolar macrophages represent a relatively
homogeneous cell population accessible by lung
lavage. However, success in isolating pulmonary
macrophages depends on the particular subclasses
involved, and, unfortunately, not all categories of
pulmonary macrophages can be recovered with the
same ease and purity. To our knowledge, no inves-
tigator has been able to prepare a pure suspension
of interstitial pulmonary macrophages. Techniques
for dissolving the lung and liberating individual cells
are being developed and intensive efforts are un-
derway with regard to separation of isolated lung
cells. However, interstitial macrophages are less
numerous and little is known about the existence of
unique physical or chemical properties which could
be exploited in separating these cells. Conceivably,
their tendency to attach themselves toglass or some
specific surface receptor could be exploited. If a
lung which has been washed to eliminate airway
and alveolar macrophages, was dispersed, presum-
ably those cells attaching to glass represent a
relatively enriched population of interstitial macro-
phages.
Improved assays for identifying pulmonary car-
cinogens also need to be developed. One approach
is to administer the suspected material to a labora-
tory animal by intratracheal instillation. Saffioti (31)
has developed such an approach, and it has been
firequently imitated. An alternative to experimental
carcinogenesis has been implemented by Ames et
al. (32). This test operates under the working hy-
pothesis that carcinogens are also mutagens. Using'
an in vitro bacterial test system (Salmonella
typhimurium) Ames et al. have been able to detect
known classes of mutagens at very low con-
centrations. The Ames assay is based on the use of
controlled mutation of the bacterial strain for de-
tecting mutagens by a highly sensitive and con-
venient back mutation test. The relatively small
genome (approx. 4 x 106 base pairs), the large
number of organisms exposed (approx. 109 per
plate), and positive selection ofmutants are some of
the advantages of this system. In addition, many
chemical carcinogens become powerful mutagens
through in vivo metabolic activation, so addition of
various cell suspensions to the test culture is
another important feature.
Conclusions
Pollutants characteristic of occupational and
urban environments, bacteria, viruses, and other in-
fectious particles, allergens, and antigens all may
cause or aggravate pulmonary disease (Table 3).
Furthermore, the magnitude of these effects is
strongly influenced by the number ofparticles depo-
sited, their site of deposition, and especially their
ultimate fate. Thus, environmental factors represent
a major area ofconcern. Death rates for lung cancer
and pulmonary emphysema have been steadily in-
creasing over the last half century. Chronic nons-
pecific pulmonary disease has become a leading
cause of death and disability in adult males.
Cigarette smoking is the major cause of this
epidemic, but community air pollution and industrial
exposures are also a major significance.
Recommendations
It is important to realize that factors within the
laboratory environment may influence the response
of animals to inhaled particles and vapors. Such
diverse influences as dietary components and con-
taminants, caging conditions, (bedding, cleanliness,
crowding, lighting, temperature), nutritional defi-
ciency, disease, as well as such factors as insec-
ticides and pesticides which are used to keep animal
facilities insect- or pest-free must be better under-
stood and quantified.
The properties of the bronchial epithelium may
be critical in relation to the development of lung
disease. The epithelium is both a surface that can
respond, and a barrier which is occasionally
crossed. A great deal is known about the epithelial
lining of the gastrointestinal tract and its relation-
ship to the movement of particles, molecules,
electrolytes, and water. Similar information ought
to be gathered about the bronchial epithelium.
Support for studying the effects of air pollution
should be continued. Such studies are essential in
determining mechanisms ofbiological response and
as part of systematic studies ofdose-response rela-
tionships. They also may be used as animal models





























Diatomaceous earth, silica gel
Asbestos, sillimanite, talc, sericite
Mica, Fuller's Earth, kaolin, cement dust
Coal, graphite, carbon black, soot, charcoal
Iron, barium, tin
Moldy hay ("farmer's lung"), mushroom compost, bagasse (sugar cane), maple
bark, B. siubtilis enzyme (detergents), malt, grain-weevil, cork, roof-thatch,
lycoperdon, cotton, flax, hemp, jute, sisal, thermiophilic actinomycetes
Pigeons, parrots, buderigars, hens, pituitary snuff
Oxides ofnitrogen (silo filler's disease) sulfur dioxide, ammonia, chlorine ozone,
phosgene, carbon tetrachloride, hydrogen chloride, chlorinated camphrene,
chloropicrin, "smoke"
Beryllium, silicide, mercury, cadmium, platinum, magnanese, zinc, vanadium
pentoxide, nickel, osmium
Polytetrafluoroethylene, toluene diisocyanate (TDI)
Mineral oil, "cutting" oils, copper sulfate
Tuberculosis (miners, nurses, pathologists),
Anthrax (wool, mohair, and alpaca workers)
Glanders (grooming of horses, mules)
Psittacosis (pet shops, turkey dressings, pigeons)
Variola (smallpox handlers)
Q fever (lab workers, abattoirs)
Coccidiomycocis (irrigation, farm work, archeology)
Histoplasmosis (poultry, pigeons, starlings)
Cryptococcosis (pigeons)
Arsenic, cobalt, nickel, hematite, uranium (pitch blends, "yellow cake") iso-








"From Trieff and Corrigan (33).
for the effects of new products. Systematic expo-
sure ofanimals to materials produced by technolog-
ical advance would permit some assessment of the
effects of these materials.
The effects of parameters which may modulate
the pulmonary response to atmospheric and indus-
trial contaminants should be measured. The effects
of medications, altered physiological states, and
concurrent illness should be systematically ex-
plored. Meteorologic variables (temperature, fog)
and factors in the organism such as exercise, dis-
ease, or allergic states, adaptation, and presence of
other foreign chemicals should also be considered.
Support for lung research is supplied by a number
of Federal agencies, such as NHLBI, EPA,
NIOSH, ERDA, as well as NIEHS. Coordination
and integration among these different organiza-
tions is frequently inadequate. Mechanisms should
be developed for finding out about each other's
grant programs, contract programs, and in-house
research. Also, a published inventory of major
facilities which are essential in health effects re-
October 1977 123search would encourage more efficient use of
scarce and expensive resources. Sophisticated en-
vironmental exposure chambers, for example, now
exist and might be made available to visiting scien-
tists.
A frequent response to environmental insult is
the deposition of fibrous connective tissue (a scar)
usually known as pulmonary fibrosis or proteolysis
and alveolar wall destruction leading to em-
physema. These responses are common to a
number of inhaled particles and gases. Our under-
standing of these diseases and appropriate
strategies for their prevention and control would be
helped by a better understanding of the synthesis
and degradation of collagen in the lung, since it is
the primary connective tissue protein. Similar
studies should be carried out with regard to pulmo-
nar-y elastin.
Diseases such as bronchial asthma, Farmer's
Lung, diffuse hypersensitivity pneumonitis, and
sai-coidosis are all examples of pulmonary diseases
characterized by immunologic abnormalities. Many
of the symptoms of asthma appear to be mediated
by various chemicals released from lung cells.
Further reseai-ch is needed to define other
mediators, to determine where and how they act,
and to learn what environmental materials govern
their release.
Frequently important contributions to our under-
standing of environmental disease have depended
upon the existence of appr-opriate animal models.
These are most helpful when the animals react to
disease as humans do. Additional research which
will develop and exploit animal analogs of en-
vironmental disease processes common to man
should be suppor-ted.
New indices of exposure need to be developed.
Breath analysis may be exploited as an indicator of
exposure. Lung analysis at autopsy may also yield
useful information about retention levels of pollu-
tants. Noninvasive approaches to intact animals
and people, such as whole body counting of
radioactive materials or the use of magnetic mea-
surements as a possible index of asbestos exposure,
should be exploited.
More sensitive and specific indices of injury
should be developed. Early detection should be a
major goal especially when reversibility is possible.
For large segments of the population, industrial
and atmospheric contaminants aggravate existing
lung injury. More research is needed concerning the
influence of disease states on the response to en-
vironmental agents. Animal models of asthma, em-
physema, lung cancer, and newborn and adult res-
piratory distress syndrome all need to be better de-
veloped and defined and then used in these kinds of
experiments. Similarly, such important agents as to-
bacco and alcohol need to be studied in regard to
possible synergistic action.
Pulmonary metabolism needs to be better de-
scribed. We need to understand how environmental
contaminants are either degraded or made more
toxic by the lung. The use of isolated cells, the iso-
lated perfused lung, whole animals, and other test
systems can lead to improved understanding.
Species differences in lung structure, function,
endemic disease, and susceptibility to environmen-
tal agents need to be better determined. Compara-
tive studies of the physiology, biochemistry, and
morphology of the lung should be encouraged in
order to provide a logical basis for understanding
the mechanisms of environmental influence and
comparing results in animals and man.
Pyrolysis products, either as a result of industrial
processes or as a result of unwanted fires, cause
frequent exposure. Better analysis of the chemical
composition of pyrolysis products and of their im-
pact on the lung and other organs is needed.
Since so many diseases of the lung are poorly
diagnosed and/or treated, more emphasis needs to
be given to preventive strategies. The design of
adequate legislation, testing of new materials and
especially compliance with existing laws, all need to
be studied. Frequently, we are dealing with factors
influencing human behavior (i.e. use of protective
equipment and safety strategies). Factors affecting
individual compliance need to be better understood.
All organisms undergo a normal developmental
sequence beginning with conception and leading to
death. The conditions of each developmental stage
may influence the response of the lung and of the
organism to environmental insult and should be bet-
ter studied. Very young and very old animals
should be exposed to both air pollutants and parti-
cles and gases characteristic of industrial environ-
ments. Age-related responses must be more
thoroughly described.
Chamber concentrations of pollutants do not
adequately define dose since deposition is influ-
enced by exercise, circadian rhythms, level ofactiv-
ity, and other factors. The effective dose is further
modified by clearance pathways and by metabolic
changes which make the compounds more or less
toxic. Whenever possible, the effective tissue dose
at the site ofaction in the lung should be measured.
The time course ofdamage, recovery, repair, and
adaptation to inhaled particles and vapors must be
described. This description is essential to an under-
standing of mechanisms involved in damage. This
history also influences the design ofexperiments by
predicting optimal times for sampling.
Our understanding of almost all environmental
Environmental Health Perspectives 124lung disease would be greatly enhanced by a more
thorough knowledge of the cell biology and
physiology of the lungs. Important clues to the
cause and prevention ofenvironmental lung disease
have frequently come from scientists working in un-
related areas. Thus future progress in controlling
environmental lung disease will depend in part on
strong support for basic research in a variety of
fields of science, as well as those fields directly
concerned with the environment and the lung.
Too little is known about what influences an
individual's decision to help or hinder his or her
pulmonary health. Addictive cigarette smoking or
compliance with preventive strategies such as res-
pirators are two examples. Research should focus
on the mechanisms of motivation for self-help or
self-destruction. Similarly, research should be sup-
ported on the effectiveness of various education
campaigns designed to influence human behavior.
Bronchial mucus is a major factor in the defense
mechanisms of the lung as well as a component
capable of response. The structure, synthesis,
physical, chemical and rheological characteristics
of mucus and periciliary fluid need to be better
elucidated.
Studies aimed at identifying specific causative
agents in cigarette smoke should be continued. The
presence of certain carcinogens, such as polycyclic
hydrocarbons and 210Po, have been suggested as
having major importance. Animal experiments
should be carried out with animals exposed to
cigarettes with these materials selectively removed.
Steps should be taken to determine whether low tar
and nicotine cigarettes are less hazardous than
others. The possibility that combinations of agents
rather than single components are responsible must
be kept in mind. Research should not focus exclu-
sively on carcinogenesis, but also on the many
other deleterious effects of cigarette smoke on the
respiratory and cardiovascular systems. Aggressive
steps toward developing a safe cigarette should be
undertaken.
Additional studies should be carried out to de-
termine whether cigarette smoking has a synergistic
action with other materials in the production ofem-
physema, cancer, asthma, and other pulmonary
diseases. Such synergism seems to exist between
cigarette smoking and asbestos exposure as well as
exposure to radon-daughters, which are found in
uranium mines. Experiments of this sort should be
carried out in animals as well as in human
epidemiological studies.
Our knowledge of the effects of indoor climate is
limited. Widespread use of artificial ventilation,
heating, and cooling of indoor air influence the
lungs to a degree which is now uncertain. Building
materials may emit noxious substances into indoor
air, or conversely may serve to reduce indoor air
pollution through absorption on indoor surfaces.
Additional studies are needed to ascertain the influ-
ence of indoor climate on the lungs.
The lung is composed of many different cell
types. Loss and replacement of these play an im-
portant role in the response to environmental pol-
lutants. Measurements of turnover rates of lung
cells and the changes in these rates relative to en-
vironmental insult require further study.
Because environmentally induced emphysema,
chronic bronchitis, and lung cancer are usually ir-
reversible by the time they are diagnosed, improved
techniques and devices are needed to detect early
biochemical, immunologic or physiologic abnor-
malities associated with development of these dis-
eases.
This material is drawn from a Background Document pre-
pared by the author for the NIEHS Second Task Force for
Research Planning in Environmental Health Science. The Re-
port of the Task Force is an independent and collective report
which has been published by the Government Printing Office
under the title, "Human Health and Environment-Some Re-
search Needs." Copies of the original material for this Back-
ground Document, as well as others prepared for the report can
be secured from the National Technical Information Service,
U.S. Department ofCommerce, 5285 Port Royal Road, Spring-
field, Virginia 22161.
These investigations were supported by grants ES 01016 and ES
00002 from the National Institute of Environmental Health Sci-
ences and Grant HL 19170 from the National Heart, Lung, and
Blood Institute.
REFERENCES
1. Hatch, T. F., and Gross, P. Pulmonary Deposition and Re-
tention of Inhaled Aerosols, Academic Press, New York,
1964.
2. Brain, J. D., and Valberg, P. A. Models of lung retention
based on the report of the ICRP Task Group. Arch. Envi-
ron. Health 28: 1 (1974).
3. Lippman, M., et al. Effects of Inhaled Particles on Man and
Animals, Part I: Deposition, Retention, and Clearance. Na-
tional Research Council, 1977.
4. Green, G. M., and Kass, E. H. The role of the alveolar
macrophage in the clearance of bacteria from the lung.
J. Exp. Med. 119: 167 (1964).
5. Schiller, E. Inhalation, retention, and elimination of dusts
from dogs' and rats' lungs with special reference to the al-
veolar phagocytes and bronchial epithelium. In: Inhaled
Particles and Vapours, C. N. Davis, Ed., Pergamon Press,
London, 1961.
6. Sorokin, S. P., and Brain, J. D. Pathways of clearance in
mouse lungs exposed to iron oxide aerosols. Anat. Rec. 181:
581 (1975).
7. Florey, H. W., General Pathology. Lloye-Luke, London, 4th
ed., 1970.
8. Robbins, S. L., and Angel, M. Basic Pathology. W. A.
Saunders, Philadelphia, 1971.
9. Bradley, K., McConnel-Breul, S., and Crystal, R. G. Col-
lagen in the human lung. J. Clin. Invest. 55: 543 (1975).
October 1977 12510. Hance, A. J. The connective tissue oflung. Am. Rev. Resp.
Dis. 112: 657 (1975).
11. Davis, J. M. G. In: Biological Effects of Asbestos. Int.
Agency Res. Cancer, Lyons, 1973.
12. Allison, A. C. Effects ofasbestos particles on macrophages,
mesothelial cells and fibroblasts. In: Biological Effects of
Asbestos. Int. Agency Res. Cancer, Lyons, 1973.
13. Richards, R. J., Wusterman, F. S., and Dodgson, K. S. The
direct effects of dusts on lung fibroblasts in vitro. Life Sci-
ences 10: 1149 (1970).
14. Maroudas, N. D., O'Neill, C. H., and Stanteen, M. F.
Asbestos induced tumours: fibroblast anchorage as a factor
in carcinogenesis by fibres. Nature 244: 353 (1973).
15. Heppleston, A. G., and Styles, J. A. Activity of a ma-
crophage factor in collagen formation by silica. Nature
214: 521 (1967).
16. Allison, A. C. Pathogenic effects of inhaled particles and
antigens. Ann. N. Y. Acad. Sci. 221: 2 (1974).
17. Allison, A. C., Harington, J. S., and Birbeck, M. An ex-
amination of the cytotoxic effects of silica on macrophages.
J. Exp. Med. 124: 141 (1966).
18. Bendixen, G. Classification ofhypersensitivity in relation to
clinical disease. Ann. Int. Med. 64: 668 (1966).
19. Rose, B., and Phills, A. The immune reaction in pulmonary
disease. Arch. Environ. Health 14: 97 (1967).
20. Pepys, J., et al. Farmer's lung. Thermophilic actinomycetes
as a source of "farmer's lung hay" antigen. Lancet 2: 607
(1963).
21. Pepys, J. Hypersensitivity Disease ofthe Lungs Due to Fungi
and Other Organic Dusts. Monographs in Allergy, 4. S.
Karger, Basel, 1969.
22. Selikoff, 1. J., Churg, J., and Hammond, E. C. Asbestos
exposure and neoplasm. J. Amer. Med. Assoc. 188: 222
(1964).
23. Selikoff, 1. J., Hammond, E. C., and Churg, J. Asbestos
exposure, smoking, and neoplasia. J. Amer. Med. Assoc.
204: 106 (1968).
24. Doll, R., et al. Mortality of gas workers-final report of a
prospective study. Brit. J. Ind. Med. 29: 394 (1972).
25. Wagoner, J. K., et al. Cancer mortality patterns among
U. S. uranium miners and millers, 1950-1962. J. Natl. Canc.
Inst. 32: 781 (1964).
26. Bidstrup, R. L., and Case, R. A. Carcinoma of the lung in
workmen in the bichromates producing industry in Great
Britain. Brit. J. Ind. Med. 32: 62 (1975).
27. Pederson, E., Hogetver, A. C., and Andersen, A. Cancer
of the respiratory organs among workers at a nickel refinery
in Norway. Int. J. Cancer 12: 32 (1973).
28. Task Group on Lung Dynamics. Deposition and retention
models for internal dosimetry ofthe human respiratory tract.
Health Phys. 12: 173 (1966).
29. Brain, J. D., Sorokin, S. P., and Godleski, J. J. Structure,
origin and fate ofthe macrophage. In: Respiratory Defense
Mechanisms (Lung Biology in Health and Disease, Mono-
graph 5), J. D. Brain, D. F. Proctor, and L. Reid, Eds.
Marcel Dekker, New York, 1977.
30. Weibel, E. R. Morphological basis of alveolar-capillary gas
exchange. Physiol. Rev. 53: 419 (1973).
31. Saffiotti, U., Cefis, F., and Kolb, L. H. A method for the
experimental induction ofbronchiogenic carcinoma. Cancer
Res. 28: 104 (1968).
32. Ames, B. N., et al. An improved bacterial test system for
the detection and classification of mutagens and car-
cinogens. Proc. Nat. Acad. Sci. 70(3): 782 (1973).
126 Environmental Health Perspectives